Lee T. Schalop - Aug 19, 2025 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Role
Director
Signature
/s/ Lee T. Schalop
Stock symbol
LTRN
Transactions as of
Aug 19, 2025
Transactions value $
$0
Form type
4
Date filed
8/20/2025, 06:25 PM
Previous filing
Jul 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schalop Lee Troy Director 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS /s/ Lee T. Schalop 2025-08-20 0002072339

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LTRN Stock Option (Right to Buy) Award $0 +5K $0.00 5K Aug 19, 2025 Common Stock 5K $4.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Equity Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing September 19, 2025.